secwatch.observer — SEC 8-K summary
======================================

Issuer:     Polomar Health Services, Inc. (PMHS)
CIK:        0001265521
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001641172-25-025989
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Polomar Health partners with ForHumanity; $750K guaranteed for exclusive marketing of inhalable drugs
--------------------------------------------------------------------------------

- Guaranteed payments of $750K; $200K already received, with remaining $500K due by Oct 31, 2025.
- Exclusivity for inhalable sildenafil and eletriptan through March 31, 2026, extendable via revenue milestones (e.g., $1.5M by Mar 31, 2026; $3M by Jun 30, 2026; $8M for FY 2026).
- Initial term 42 months (Mar 17, 2025 – Sep 16, 2028) with automatic renewals if average annual revenues meet $3M (first renewal) and $6M (second renewal).
- Fulfillment by Polomar Specialty Pharmacy; IG4 handles account management; additional $50K advance due by Sep 15, 2025.
- Product pricing capped at 3% annual increase during initial term; Polomar must reserve 8,000 kits of each product for ForHumanity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1265521/000164117225025989/0001641172-25-025989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1265521/000164117225025989/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-025989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer